About Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas.
 
Company Headquarters
Headquarter of Novartis International AG Novartis International AG
CH-4002 Basel
Switzerland

Telephone Tel: +41 61 324 11 11

Fax Tel: +41 61 324 80 01
See more images of Novartis Basel campus
 
Recent media releases
8/30/2010
Novartis International BioCamp provides forum for future research and business leaders to engage in scientific innovation

8/27/2010
Novartis drug Tasigna® approved in Switzerland after fast-track review for treatment of patients with newly diagnosed Ph+ CML

8/27/2010
Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure

 

Top products

Product Full Year 2009 Product Sales Therapeutic Area
USD m variance in USD
Diovan Logo 6,013 5% Cardiovascular and Metabolism
glivec Logo 3,944 7% Oncology
Zometa Logo 1,469 6% Oncology
Femara Logo 1,266 12% Oncology
Lucentis Logo 1,232 39% Neuroscience and Ophthalmics

See more product information

 

Awards

2009 Fortune - World's Most Admired Companies® DiversityInc ranks Novartis No. 7 in its Top 10 Companies for Global Diversity in 2010. In 2009, Novartis was No. 8 on this list.
Dow Jones Sustainability Indexes - Member 2009/10 Novartis recognized in the "World's Most Innovative Companies" list by Fast Company magazine. Novartis listed as No. 8 on the overall company list, as well as No. 1 on the biotechnology sector list.
Read more about Novartis rankings and awards